Differential Gene Expression Profile Associated with the Abnormality of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Li, Jianping ^a,b   Yang, Shaoguang ^a   Lu, Shihong ^a   Zhao, Hui ^c   Feng, Jianming ^b   Li, Wenqian ^b   Ma, Fengxia ^a   Ren, Qian ^a   Liu, Bin ^a   Zhang, Lei ^a   Zheng, Yizhou ^a   Han, Zhong Chao ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b QINGHAI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c TIANJIN UNIVERSITY OF COMMERCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; ADOLESCENT; ADULT; APLASTIC ANEMIA; APOPTOSIS; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL STRUCTURE; CHEMOTAXIS; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; BONE MARROW; CASE CONTROL STUDY; CELL SHAPE; GENE EXPRESSION REGULATION; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

TRANSCRIPTOME;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; APOPTOSIS; BONE MARROW; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTOME; YOUNG ADULT;

EID: 84868340676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047764     Document Type: Article

References (27)

1. Young NS, Calado RT, Scheinberg P, (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108: 2509-2519.
2. Li JP, Zheng CL, Han ZC, (2010) Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Crit Rev Oncol Hematol 75: 79-93.
3. Zoumbos NC, Gascon P, Djeu JY, Young NS, (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 82: 188-192.
4. Verma A, Deb DK, Sassano A, Kambhampati S, Wickrema A, et al. (2002) Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia. J Immunol 168: 5984-5988.
5. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, et al. (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100: 1185-1191.
6. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS, (1996) A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood 88: 1983-1991.
7. Manz CY, Nissen C, Wodnar-Filipowicz A, (1996) Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment. Am J Hematol 52: 264-274.
8. Schrezenmeier H, Jenal M, Herrmann F, Heimpel H, Raghavachar A, (1996) Quantitative analysis of cobblestone area-forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. Blood 88: 4474-4480.
9. Rizzo S, Scopes J, Elebute MO, Papadaki HA, Gordon-Smith EC, et al. (2002) Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow. Hematol J 3: 230-236.
10. Philpott NJ, Scopes J, Marsh JC, Gordon-Smith EC, Gibson FM, (1995) Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Exp Hematol 23: 1642-1648.
11. Timeus F, Crescenzio N, Doria A, Foglia L, Linari A, et al. (2005) Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia. Exp Hematol 33: 597-604.
12. Callera F, Falcao RP, (1997) Increased apoptotic cells in bone marrow biopsies from patients with aplastic anaemia. Br J Haematol 98: 18-20.
13. Killick SB, Cox CV, Marsh JC, Gordon-Smith EC, Gibson FM, (2000) Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol 111: 1164-1169.
14. Zeng W, Chen G, Kajigaya S, Nunez O, Charrow A, et al. (2004) Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. Blood 103: 325-332.
15. Zeng W, Kajigaya S, Chen G, Risitano AM, Nunez O, et al. (2004) Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. Exp Hematol 32: 806-814.
16. Uccelli A, Moretta L, Pistoia V, (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
17. Chen X, Armstrong MA, Li G, (2006) Mesenchymal stem cells in immunoregulation. Immunol Cell Biol 84: 413-421.
18. Rasmusson I, (2006) Immune modulation by mesenchymal stem cells. Exp Cell Res 312: 2169-2179.
19. Bacigalupo A, Valle M, Podesta M, Pitto A, Zocchi E, et al. (2005) T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 33: 819-827.
20. Chao YH, Peng CT, Harn HJ, Chan CK, Wu KH, (2010) Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann Hematol 89: 715-723.
21. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, et al. (2009) Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147: 43-70.
22. Li J, Zhao Q, Xing W, Feng J, Wu H, et al. (2011) Interleukin-27 enhances the production of tumour necrosis factor-alpha and interferon-gamma by bone marrow T lymphocytes in aplastic anaemia. Br J Haematol 153: 764-772.
23. Steiner RM, Mitchell DG, Rao VM, Murphy S, Rifkin MD, et al. (1990) Magnetic resonance imaging of bone marrow: diagnostic value in diffuse hematologic disorders. Magn Reson Q 6: 17-34.
24. Negendank W, Weissman D, Bey TM, de Planque MM, Karanes C, et al. (1991) Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders. Blood 78: 2872-2879.
25. Li JP, Lu SH, Yang SG, Xing W, Feng JM, et al. (2012) Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4+ T cells in aplastic anemia. Results in Immunology 2: 142-147.
26. Jaganathan BG, Tisato V, Vulliamy T, Dokal I, Marsh J, et al. (2010) Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation. Leukemia 24: 1791-1795.
27. Wang H, Wang Z, Xue M, Liu J, Yan H, et al. (2010) Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic. Cytotherapy 12: 563-565.